We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-2 of 2

The path forward: poison pills in Canada after Pulse Data, Neo and Lions Gate
  • Osler Hoskin & Harcourt LLP
  • Canada
  • September 30 2010

Recent decisions of the Alberta, Ontario and British Columbia securities commissions on applications to set aside shareholder rights plans or "poison pills" adopted in response to a hostile take-over bid have called into question whether Canadian securities regulators now hold a consistent view as to when it will be appropriate for a commission to intervene to remove a shareholder rights plan as an obstacle to individual shareholders deciding for themselves whether to tender their shares to the bid